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INTRODUCTION
Obstructive uropathy affects approximately 10% of Americans 1 . If left untreated, it can lead to inflammation, atrophy, fibrosis, and irreversible renal injury ending in chronic kidney disease 2 , which can significantly burden both patients and the health care system 3 .
A proposed mechanism of obstructive uropathy postulates that injured kidney epithelial cells express cytokines that lead to leukocyte infiltration. These leukocytes subsequently release a variety of mediators such as transforming growth factor beta-1 (TGF-β1) 2 . Regulated by angiotensin II (ANGII) 4 , TGF-β1 is an inducer of epithelial-mesenchymal transition (EMT), a key initiator of tissue fibrosis. Tubulointerstitial fibrosis can lead to tissue damage, loss of function and irreversible injury 5, 6 .
While effective surgical and non-surgical procedures are available to abrogate urinary obstruction, patients can experience long wait times between initial consultation and medical intervention, ultimately causing renal injury to accumulate. Current pharmacological treatments aimed at limiting renal injury during obstruction are scarce. Recent evidence suggests that gasotransmitters (small, endogenously-produced gaseous molecules) can exhibit antiinflammatory and vasodilatory effects in tissue injury 7, 8 . H 2 S is endogenously produced by cystathionine β-synthase, cystathionine γ-lyase, and 3-mercaptopyruvate sulfurtransferase, and can mediate cellular signaling, vasodilation, apoptosis and inflammation 8 .
Two recent studies have demonstrated that exogenous H 2 S, released via sodium hydrosulfide (NaHS), can ameliorate damage associated with short-term ureteral obstruction 9, 10 .
While histopathological analyses were performed, these studies did not evaluate functional M A N U S C R I P T
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changes. Additionally, as NaHS generates supra-physiological quantities of H 2 S spontaneously in solution and has a half-life of only 15 minutes, it is a difficult potential therapeutic tool.
GYY4137 is an H 2 S donor molecule that allows for slow and extended release of H 2 S over a 24-hour period 11 . Unlike NaHS, GYY4137 results in a sustained elevation of plasma H 2 S levels upon intraperitoneal (IP) and intravenous (IV) administration 11 . GYY4137 also possesses significant anti-inflammatory, anti-oxidant and anti-apoptotic characteristics, as demonstrated by our lab and others, which makes it an ideal potential therapy against renal injury [12] [13] [14] [15] .
In the present study, we examined the effects of daily supplemental GYY4137 on serum biochemistry, glomerular function and histopathological parameters associated with a rat model of chronic unilateral ureteral obstruction (UUO) 5 . We evaluated the potential mechanisms behind our findings by examining tissue protein expression and via an in vitro scratch assay 16 . We demonstrate, for the first time, that exogenous H 2 S treatment during chronic ureteral obstruction can preserve overall renal function, decrease inflammatory damage and attenuate fibrosis via a TGF-β1-and ANGII-mediated mechanism. Thus, H 2 S supplementation is a potential therapy in the management of ureteral obstruction.
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MATERIALS AND METHODS
Animal description and care
Adult 
Unilateral ureteral obstruction (UUO) procedure and postoperative monitoring
UUO is a common model used to simulate obstruction and induce fibrosis 5 . Rats were randomly divided into four groups: Sham (n=5), Sham+GYY4137 (n=5), UUO (n=8), and UUO+GYY4137 (n=7). All rats were anesthetized with ketamine and isoflurane. Sham rats underwent an abdominal incision and closure. To permanently ligate the left ureter in the UUO and UUO+GYY4137 groups, silk ties were placed across the left ureteropelvic junction. All animals were monitored for 30 days post-operatively. Animals in the UUO group were administered daily IP injections of phosphate buffered saline (PBS) vehicle (0.1 mL).
UUO+GYY4137 and Sham+GYY4137 animals were given daily IP injections of GYY4137 (200 µmol/kg GYY4137 in 1 mL PBS; 1mL of PBS was required to dissolve GYY4137). GYY4137
was not dissolved in DMSO as it was being injected over an extended period of time. 
Histological staining
Tissues were fixed in 10% formalin, embedded in paraffin and sectioned. Sections were stained with Masson's trichrome and terminal deoxynucleotidyl-transferase-mediated dUTP nick end labeling (TUNEL) to assess fibrosis and apoptosis, respectively. Immunohistochemical (IHC) staining with antibodies against CD68 (Abcam) and myeloperoxidase (MPO, Abcam) were used to determine macrophage and neutrophil infiltration, respectively. Sections were stained with hematoxylin and eosin (H&E) to determine cortical thickness.
Image Analysis
In a blinded fashion, TUNEL, IHC and Masson's trichrome sections were imaged using a Using the Ambion PARIS kit (Life Technologies), total RNA was extracted from renal tissue and reverse transcribed into cDNA using SuperScript VILO MasterMix (Life Technologies) as per manufacturer's protocol. Concentrations were determined using NanoDrop 1000 Spectrophotometer (Thermo Scientific). qPCR was performed using Fast SYBR Green PCR Master Mix (Life Technologies) and analyzed using CFX96 Real Time System thermal cycler and CFX Manager Software (Bio-rad Laboratories). Primer sequences were designed using PrimerQuest (Integrated DNA Technologies) against glyceraldehyde 3-phosphate dehydrogenase (GAPDH), ANGII receptor type 1 (ANGIIR1), fibronectin, vimentin, TGF-β1, TGF-β1 receptor 2 (TGF-β1R2) and Smad2 (Table 1) . GAPDH served as a reference gene, and fold-change in gene expression was calculated via the ∆∆Ct method.
Western Blot Analysis
Total protein was extracted from kidney homogenate using the Ambion PARIS kit (Life Technologies) as per manufacturer's protocol. Lysate concentrations were quantified using the NanoDrop 1000 Spectrophotometer (Thermo Scientific). 30 µg of protein was separated by SDS-PAGE, transferred onto a nitrocellulose membrane and probed with antibodies against β-actin 
In vitro scratch wound assay
In vitro scratch wound assays were performed to investigate the effects of GYY4137 on the migratory properties of EMT 16 . In 24-well plates, LLC-PK1 cells were seeded at 1. 
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RESULTS
GYY4137 treatment decreased serum creatinine and proteinuria during chronic UUO.
SCr was significantly higher on POD3 in both UUO and UUO+GYY4137 when compared to Sham (p<0.01, p<0.0001). However, SCr of UUO+GYY4137 decreased to Sham levels on POD10, whereas SCr of UUO group remained elevated until POD20 (p<0.05). SCr of UUO and UUO+GYY4137 remained similar to Sham on POD20 and POD30 ( Figure 1A ).
Interestingly, urine protein to creatinine excretion ratio (UPr/Cr) of UUO group was significantly higher compared to Sham on POD3 (p<0.05) and remained slightly elevated until POD30, whereas the UUO+GYY4137 group demonstrated normal UPr/Cr throughout the experiment ( Figure 1B ). No differences in SCr and UPr/Cr were observed between Sham+GYY4137 and
Sham animals ( Figure 1 ).
GYY4137 treatment did not affect long-term apoptosis
TUNEL stain was used to determine the level of apoptosis. At POD30, all groups exhibited similar levels of apoptosis ( Figure 2 ).
GYY4137 retained renal cortical thickness following long-term obstruction
Tissue sections were stained with H&E, and cortical thickness was measured ( Figure 3A , representative images). On POD30 following UUO, there was a significant decrease in cortical thickness in both treatment groups when compared to the Sham animals (p<0.0001). However, the daily administration of GYY4137 was protective and led to a lesser decline in cortical thickness compared to the UUO group treated with vehicle (p<0.05) ( Figure 3B ). No difference in renal cortical thickness was observed between Sham and Sham+GYY4137 groups ( Figure 3 ).
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GYY4137 did not affect long-term inflammation
Kidney sections were immunohistochemically stained with antibodies against macrophage marker CD68 and neutrophil marker MPO. The number of CD68-positive cells in the UUO and UUO+GYY4137 were elevated compared to Sham (p<0.01) on POD30 ( Figure   4A ). There was a slight increase in neutrophil infiltration in both UUO and UUO+GYY4137 groups compared to Sham (p=0.101 and p=0.515, respectively), although the effects appeared to be slightly blunted in the UUO+GYY4137 group ( Figure 4B ). Sham and Sham+GYY4137 groups displayed similar levels of inflammatory infiltrate ( Figure 4 ).
Supplemental GYY4137 mitigated renal fibrosis during chronic UUO
Fibrosis was detected through histological staining with Masson's trichrome, with fibrotic areas staining blue ( Figure 5A ). On POD30, there was a significant increase in the percent fibrosis of the obstructed kidney in the UUO group (p<0.001) which was significantly decreased to Sham levels in the UUO+GYY4137 animals (p<0.01) ( Figure 5B ). We observed no difference in renal fibrosis between Sham and Sham+GYY4137 groups ( Figure 5 ).
GYY4137 attenuated migration associated with EMT
To assess the effect of GYY4137 on the migratory properties of EMT, a scratch wound assay was performed. Migration was determined based on the rate of wound closure and presented as a fold change relative to the control. Treatment with 10 ng/mL TGF-β1 increased migration in LLC-PK1 cells when compared to untreated control (p=0.131, Figure 6 ). TGF-β1-induced migration was significantly decreased upon treatment with 10 µM GYY4137 and 50 µM GYY4137 (p<0.05, Figure 6 ).
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GYY4137 mitigated expression of EMT inducers and markers
Expression of EMT markers were determined through qRT-PCR analysis of left kidney tissue obtained at POD30. Upregulation of ANGIIR1, TGF-β1, TGF-β1R2, Smad2, Col1α1, fibronectin and vimentin were observed in both UUO and UUO+GYY4137 groups when compared to Sham. Interestingly, the UUO+GYY4137 group demonstrated a significant decrease in expression of ANGIIR1, Col1α1, fibronectin, vimentin, and Smad2 (p<0.05), and a marked decrease in expression of TGF-β1 and TGF-β1R2 when compared to UUO (Figure 7 ). Western
Blot analysis at POD30 ( Figure 8A ) showed increased TGF-β1R2 and vimentin expression in UUO and UUO+GYY4137 groups when compared to Sham (p=0.096 and p=0.100, respectively). In keeping with the mRNA expression, both TGF-β1R2 and vimentin responses were diminished in the UUO+GYY4137 group when compared to UUO group (p=0.478 and p=0.846, respectively; Figure 8B ).
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DISCUSSION
Recent studies have identified H 2 S as an endogenous gasotransmitter and a key modulator of physiological responses. In the kidney, H 2 S plays a critical role in regulating renal function, fibrosis and inflammation 7, 8, 17 . Here, we examined the effects of the H 2 S donor GYY4137 on a chronic model of UUO. We found that the exogenous administration of a longacting H 2 S donor alleviated tissue injury associated with chronic obstruction.
Immediately following UUO, SCr in both UUO and UUO+GYY4137 groups were significantly elevated when compared to Sham. This was unexpected, as the contralateral kidney typically compensates for the function of the obstructed kidney. However, SCr levels of UUO+GYY4137 group returned to basal levels on POD10, while SCr levels of UUO group remained elevated. Due to its vasodilatory properties, one potential explanation for these findings is based on the ability of H 2 S to divert blood flow to the contralateral kidney through afferent arteriolar dilation (reno-renal reflex) 8, 18 . Additionally, high doses of ketoprofen were administered on POD1 and POD2 to minimize the discomfort from complete UUO; its nephrotoxic effects were reflected in the decreased glomerular filtration rate (data not shown) in both UUO and UUO+GYY4137 groups on POD3, and UUO group only on POD10. Therefore, it is likely that the nephrotoxic properties of ketoprofen masked the early remedial effect of GYY4137. Interestingly, UUO+GYY4136 group exhibited significantly lower UPr/Cr on POD10 and slightly decreased UPr/Cr on all other PODs when compared to UUO group. As proteinuria can be seen following hyperfiltration and hypertensive injury 19 , these findings demonstrate the well-established ability of H 2 S to mediate intra-renal pressure 8 . Remarkably, this was also reflected in our analysis of ANGIIR1 expression on POD30, which was significantly decreased upon treatment with GYY4137. Our data not only demonstrate the detrimental effects M A N U S C R I P T
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of UUO on overall renal function in a healthy subject, but also highlight that H 2 S can mitigate renal injury by decreasing pressure in the obstructed kidney via dilation of the efferent arteriole.
The anti-apoptotic properties of H 2 S have been well-documented in many previous studies 20, 21 . We examined the effects of H 2 S on renal apoptosis following obstruction via TUNEL staining and observed similar levels of apoptosis across all treatment groups. Previous studies have observed an acute increase in renal tubular apoptosis following UUO with a trending decline shortly thereafter, suggesting the initiation of a more fibrotic phenotype 22 . This fits well with our findings at 30 days post-UUO and highlights the importance of early decompression of the renal moiety. Future studies evaluating the reversibility of this phenotype are warranted, especially in light of our novel findings with exogenous H 2 S supplementation as a potential therapeutic strategy in UUO.
H&E sections revealed a decrease in cortical thickness of UUO and UUO+GYY4137
kidneys when compared to Sham. This is attributable to tissue atrophy and nephron loss and is an indication of irreversible kidney injury 23, 24 . Similar to previous studies, the administration of H 2 S significantly diminished cortical loss of the obstructed kidney. However, our studies showed a more marked benefit, likely due to our use of GYY4137, a more long-acting H 2 S donor compared to the sodium salts employed by other groups 10 . Our results demonstrate that exogenous H 2 S may play a protective role in the face of cortical loss during chronic obstruction.
Interestingly, we also observed an increase in cortical thickness of the contralateral kidney in UUO group, but not UUO+GYY4137 group, when compared to Sham. This compensatory hypertrophy of the contralateral kidney is typically observed following UUO and is often associated with hyperfiltration 23, 25 , which may explain the parallel increase in UPr/Cr observed M A N U S C R I P T
in UUO group. Our data demonstrate that GYY4137 may exert protective effects on both kidneys to alleviate renal injury.
TGF-β1 is a cytokine released by inflammatory cells and can cause fibrosis 26 . Through IHC, we examined the level of inflammatory infiltrate following UUO and found elevated levels of CD68-positive and MPO-positive cells. Although H 2 S did not reduce macrophage infiltration, the slight decrease in neutrophil infiltration in UUO+GYY4137 group confirms the antiinflammatory actions of H 2 S 15,20 . Previous studies found higher levels of CD68 infiltration at higher dosages of NaHS 9 , which concurred with the results obtained from our study.
Additionally, CD68 is a marker for both M1 and M2 macrophages, with pro-and antiinflammatory effects, respectively. As M2 macrophages play a critical role in kidney repair 27 , increase in CD68-positive cells may therefore reflect a surge of anti-inflammatory M2 cells.
UUO+GYY4137 animals also exhibited a significant decrease in fibrosis when compared to UUO group, which paralleled our inflammatory phenotype observations. Our data imply that exogenously administered H 2 S can abate fibrotic injury associated with long-term obstruction, possibly through modulation of the TGF-β1/Smad pathway.
The TGF-β1/Smad pathway is regulated by ANGII, an inducer of TGF-β1 expression 4 .
This pathway is a major mediator of fibrosis as it activates EMT, thereby causing epithelial cells to migrate 28 . We sought to investigate the effects of H 2 S on EMT-induced migration in kidney epithelial cells using an in vitro scratch assay. We observed a trend towards increased migration in LLC-PK1 cells upon treatment with TGF-β1, which was attenuated upon addition of GYY4137. Echoing our in vitro results, we observed elevated expressions of ANGIIR1, TGF-β1
and other EMT markers in our UUO group, which were consistently alleviated upon administration of GYY4137. These trends were also reflected in our Western Blot analysis of M A N U S C R I P T groups, we conclude that daily IP administration of GYY4137 in PBS does not induce changes in a healthy kidney.
In conclusion, the administration of exogenous H 2 S exerts protective effects against renal injury in a multifaceted manner. 
